Loading...
Loading...
Medical imaging (X-ray, CT, MRI), electronic health records, clinical trials, ECG/EEG, pathology
14,877 datasets
Yiming Shi's prospective observational study evaluates the Gastrointestinal Dysfunction Score (GIDS) in 486 adult ICU patients, 359 of whom had pre-existing digestive disease. The dataset likely contains daily scores for GIDS, SOFA, and AGI grades during the first ICU week, used to predict 28-day mortality. The study found that adding GIDS to SOFA improved discrimination, with a combined AUC of 0.764.
A prospective observational study dataset evaluating the Gastrointestinal Dysfunction Score (GIDS) for predicting 28-day mortality in ICU patients with pre-existing digestive system disease. The dataset includes 486 adult ICU patients, with 359 in the GI cohort, and was created by Yiming Shi. It was last updated on May 28, 2026.
A single-center prospective observational study of 486 adult ICU patients, including 359 with pre-existing digestive disease, conducted by Yiming Shi. The dataset, last updated in May 2026, evaluates the Gastrointestinal Dysfunction Score (GIDS) and its combination with the SOFA score for predicting 28-day mortality.
A dataset from a prospective observational study evaluating the Gastrointestinal Dysfunction Score (GIDS) in 486 adult ICU patients, including 359 with pre-existing digestive disease. The study, authored by Yiming Shi and shared on figshare, compares GIDS and the Sequential Organ Failure Assessment (SOFA) score for predicting 28-day mortality. Results indicate GIDS combined with SOFA achieved an AUC of 0.764 for mortality discrimination.
Yiming Shi's prospective observational study evaluates the Gastrointestinal Dysfunction Score (GIDS) in adult ICU patients. The dataset includes 486 patients, with 359 having pre-existing digestive system disease, and records daily GIDS, SOFA, and AGI scores for the first ICU week. The study found that combining GIDS with SOFA improved discrimination for 28-day mortality, achieving an AUC of 0.764.
Zhengtai Sun's pharmacovigilance study analyzes 92 adverse event reports for perfluorohexyloctane ophthalmic solution, a treatment for dry eye disease. The analysis uses FDA Adverse Event Reporting System (FAERS) data from Q4 2023 through Q4 2024 and employs four disproportionality methods to identify safety signals. The median time-to-onset for reported adverse events was 2 days.
92 adverse event reports for a novel dry eye disease treatment were analyzed from the FDA Adverse Event Reporting System (FAERS) between Q4 2023 and Q4 2024. Zhengtai Sun authored this pharmacovigilance study, which identified the top reported events and calculated safety signals using four disproportionality analysis methods. The median time-to-onset for reported adverse events was 2 days.
A pharmacovigilance analysis of adverse events associated with perfluorohexyloctane ophthalmic solution for dry eye disease. The dataset contains 92 adverse event reports from the FDA Adverse Event Reporting System (FAERS) database from the fourth quarter of 2023 through the fourth quarter of 2024. The study was authored by Zhengtai Sun and posted on figshare.
Zhengtai Sun conducted a retrospective pharmacovigilance analysis using the FDA Adverse Event Reporting System (FAERS) database from the fourth quarter of 2023 through the fourth quarter of 2024. The study identified 92 adverse event reports associated with perfluorohexyloctane ophthalmic solution for dry eye disease. It employed four disproportionality analysis methods to identify potential safety signals, with a median time-to-onset for adverse events of 2 days.
A retrospective pharmacovigilance study using FDA Adverse Event Reporting System (FAERS) data from the fourth quarter of 2023 through the fourth quarter of 2024 identified 92 adverse event reports associated with perfluorohexyloctane ophthalmic solution for dry eye disease. The analysis employed four disproportionality methods to detect safety signals, with a median time-to-onset of 2 days for reported events. The dataset was authored by Zhengtai Sun and shared under a CC-BY-4.0 license.
92 adverse event reports for perfluorohexyloctane ophthalmic solution were analyzed from the FDA Adverse Event Reporting System (FAERS) database from Q4 2023 to Q4 2024. The study by Zhengtai Sun, posted in 2026, employed four disproportionality analysis methods to identify potential safety signals. The median time-to-onset for reported adverse events was 2 days.
A retrospective clinical dataset of 300 acute ischemic stroke patients treated with intravenous thrombolysis, used to develop a prognostic model. The dataset includes a development cohort of 200 patients, a temporal validation cohort of 100 patients, and a dynamic substudy cohort of 150 patients with serial biomarker sampling. It was authored by Huiyuan Zhang and last updated in June 2026.
A cross-sectional study from April 4th to May 25th, 2025, assessed provider-level implementation fidelity for tuberculosis screening among diabetes patients. The dataset includes survey responses from 94 health providers across 20 public health facilities in Ubungo district, Tanzania. It was created by Edwin Christian Chavala and published on figshare under a CC-BY-4.0 license.
94 health providers from 20 public facilities in Ubungo district were surveyed from April 4 to May 25, 2025, to assess fidelity to TB screening guidelines for diabetes patients. The study, conducted by Edwin Christian Chavala, found an overall provider-level fidelity score of 83.0%, with 78 out of 94 providers reporting high fidelity. Factors like teamwork, self-efficacy, and facility level were significantly associated with implementation consistency.
A national cross-sectional survey of 143 respondents from an NF1 registry characterizes the prevalence and quality-of-life impact of body-focused repetitive behaviors (BFRBs). The dataset includes survey responses reporting BFRB types and Dermatology Life Quality Index (DLQI) scores, analyzed via multivariable logistic regression. It was published on figshare by 'figshare admin karger' and last updated on May 18, 2026.
Mohammed Abd‐Alhussein Aljodah's prospective observational study evaluates the effect of early nasal layer closure on cleft palate repair. The dataset likely contains measurements from 30 patients under 1 year of age, tracking alveolar and palatal gap reductions and fistula occurrences. The data originates from a clinical study published on paperswithcode.
A study of 11 post-hysterectomy patients with gynecologic cancers enrolled in an image-guided proton therapy protocol. Data includes computed tomography simulations with full and empty bladders, weekly/biweekly on-treatment scans, and comparative intensity-modulated radiation therapy plans. The research investigates the impact of organ motion on small bowel dose-volume relationships.
A qualitative study of 23 parents or guardians of children with phonological disorders, based on interviews analyzed via Content Analysis. The research was conducted by Roberta Michelon Melo and published via paperswithcode. The data captures parental views on therapy acceptability, perceived child difficulties, and family involvement.
Eight post-stroke subjects with oropharyngeal dysphagia participated in a study comparing traditional speech-language therapy with therapy combined with Neuromuscular Electrical Stimulation. The data includes pre- and post-treatment measurements of suprahyoid muscle contraction time and amplitude during swallowing, collected via Surface Electromyography Biofeedback. The dataset was created by researcher Maíra Barbosa Lobo and is available via the paperswithcode platform.
Leicester City Council publishes quarterly details of its contracts, commissioned activities, purchase orders, and framework agreements valued over £5,000. The data is redacted in line with Local Government Association guidance to protect personal data, commercial confidentiality, and security. It serves as a record of significant public procurement spending.